These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 37286755)

  • 1. N6-methyladenosine (m6A) Modification in Preeclampsia.
    Zhang T; Jiang Z; Yang N; Ge Z; Zuo Q; Huang S; Sun L
    Reprod Sci; 2023 Nov; 30(11):3144-3152. PubMed ID: 37286755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion.
    Zhang Y; Yang H; Long Y; Zhang Y; Chen R; Shi J; Chen J
    Sci Rep; 2021 Dec; 11(1):24357. PubMed ID: 34934095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research progress on N6-methyladenosine in the human placenta.
    Zhou W; Xue P; Yang Y; Xia L; Yu B
    J Perinat Med; 2022 Oct; 50(8):1115-1123. PubMed ID: 35606944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.
    Bian Y; Li J; Shen H; Li Y; Hou Y; Huang L; Song G; Qiao C
    FASEB J; 2022 Dec; 36(12):e22617. PubMed ID: 36412513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-methyladenosine modification in trophoblasts promotes circSETD2 expression, inhibits miR-181a-5p, and elevates MCL1 transcription to reduce apoptosis of trophoblasts.
    Wang D; Guan H; Wang Y; Song G; Xia Y
    Environ Toxicol; 2023 Feb; 38(2):422-435. PubMed ID: 36260529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-methyladenosine dynamics in placental development and trophoblast functions, and its potential role in placental diseases.
    Wu S; Liu K; Cui Y; Zhou B; Zhao H; Xiao X; Zhou Q; Ma D; Li X
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167290. PubMed ID: 38866113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the role of m6A modification in the great obstetrical syndromes.
    Ning J; Yan J; Yang H
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2234541. PubMed ID: 37474299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of METTL3 expression and m6A RNA methylation in placental trophoblasts in preeclampsia.
    Gu Y; Chu X; Morgan JA; Lewis DF; Wang Y
    Placenta; 2021 Jan; 103():43-49. PubMed ID: 33070036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene model-related m6A expression levels predict the risk of preeclampsia.
    Li Y; Chen C; Diao M; Wei Y; Zhu Y; Hu W
    BMC Med Genomics; 2022 May; 15(1):103. PubMed ID: 35513840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine (m6A) modification in gynecological malignancies.
    Zhang C; Liu N
    J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low m6A modification-mediated upregulation of PLAC8 promotes trophoblast cell invasion and migration in preeclampsia.
    Zhang Y; Guo X; Chen Z; Guo R
    Eur J Med Res; 2023 Oct; 28(1):466. PubMed ID: 37885015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of the transcriptome-wide m6A methylome in preeclampsia and healthy control placentas.
    Wang J; Gao F; Zhao X; Cai Y; Jin H
    PeerJ; 2020; 8():e9880. PubMed ID: 32983644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YTHDC1 maintains trophoblasts function by promoting degradation of m6A-modified circMPP1.
    Wang D; Guan H; Xia Y
    Biochem Pharmacol; 2023 Apr; 210():115456. PubMed ID: 36780989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic role of N6-methyladenosine (m6A) RNA methylation in the cardiovascular system.
    Zhao K; Yang CX; Li P; Sun W; Kong XQ
    J Zhejiang Univ Sci B; 2020 Jul; 21(7):509-523. PubMed ID: 32633106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethylase FTO-mediated m6A modification of SIK1 modulates placental cytotrophoblast syncytialization in type 2 diabetes mellitus.
    Ning J; Yan J; Wang S; Cui Z; Xue Y; Juan J; Yang H
    iScience; 2024 Jun; 27(6):109900. PubMed ID: 38883837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma.
    He C; Teng X; Wang L; Ni M; Zhu L; Liu J; Lv W; Hu J
    Mol Biol Rep; 2023 Oct; 50(10):8691-8703. PubMed ID: 37598390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Link Between m6A Modification and Cancers.
    Liu ZX; Li LM; Sun HL; Liu SM
    Front Bioeng Biotechnol; 2018; 6():89. PubMed ID: 30062093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
    Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
    Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-Methyladenosine-Modification-Related Ophthalmic Diseases and Potential Therapeutic Strategies.
    Chen X; Xie Y; Liu Q; Luo X; Gao Y
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):304. PubMed ID: 36472104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.